International Clinical Trial: ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830108) titled 'ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months' on Sept. 15.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Factorial Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Starship Child Health, Te Toka Tumai Auckland

Condition: Rheumatic Fever Rheumatic Heart Disease in Children Acute Rheumatic Fever Rheumatic Heart Disease

Interventi...